NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Synartro AB

Synartro AB

Private
UppsalaHealthcare & Life Scienceshttps://synartro.com/

Last Round

VC Round

Oct 9, 2024

Total Funding Raised

$6.36M

Company Overview

Synartro AB is a life science company that develops local injection treatments for osteoarthritis by combining proprietary slow-release technology with existing proven drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug deliverydrug delivery platforminflammatory disease treatmentbiopharmaclinical-stage biotechhyaluronandrug candidatetherapeutic developmentpreclinical developmentclinical trialsdrug licensinggmp manufacturingpharma r&ddrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synartro AB Comps

Public and private peers based on sector, stage, and business model.

Synartro AB comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synartro AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 9, 2024
Convertible DebtOct 9, 2024
Series AOct 25, 2021
SeedOct 2, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

Magnus Hurst

CEO (acting), CFO

Executive Team

Synartro AB Investors

Notable investors and investment history

Synartro AB investors
InvestorRounds
ScietyConvertible Debt, VC Round, Series A, Seed
Linc ABSeed, Convertible Debt, VC Round, Series A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 9, 2024

    $529K raised from Linc AB and Sciety

  • Oct 2, 2020

    $1.9M round led by Sciety

View all signals

Synartro AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synartro AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synartro AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersUppsala
Employee Range6
Year Founded2011
Last FundingOct 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.